Research trends within aneurysmal subarachnoid hemorrhage from 2017 to 2021: a bibliometric study

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
NEUROSURGICAL REVIEW, v.46, n.1, article ID 165, 11p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Bibliometric analyses are a well-established strategy for understanding the dynamics of publications. Aneurysmal subarachnoid hemorrhage (aSAH) is a hot topic in neurology and neurosurgery research. To perform a bibliometric analysis of recent publications within aSAH. Articles addressing aSAH published between 2017 and 2021 were included and had their information extracted from Scopus. A total of 2177 articles were included. The mean number of citations was 6.18 (95%CI = 5.77-6.59). 2021 and 2020 were the most prolific years. World Neurosurgery (N = 389/2,177 articles; 17,87%) was the leading publisher, and American Journal of Neuroradiology had the highest number of citations per article (14.82) among journals with & GE; 10 publications. Primary research (N = 1624/2177) predominated, followed by case reports (N = 434/2,177). Among secondary studies, systematic reviews (N = 78/119) surpassed narrative reviews (N = 41/119). USA led the number of publications (N = 548/2,177 articles; 25.17%), followed by China (N = 358/2,177 articles; 16.44%). High-income countries had a higher number of publications (N = 1624/2177) and more citations per article (6.84) than middle-income countries (N = 553/2177 and 4.25, respectively). There were zero articles from low-income countries. European and North American institutions had the greatest research impact. There was an increase in the number of published articles in the last few years (2020 and 2021). Many studies had a low level of evidence, whereas interventional studies were uncommon.
Palavras-chave
Bibliometrics, Publications, Citation analysis, Subarachnoid hemorrhage, Journal impact factor, Intracranial aneurysm
Referências
  1. Al Nemer A, 2022, ELECTRON J GEN MED, V19, DOI 10.29333/ejgm/12008
  2. Alotaibi NM, 2016, WORLD NEUROSURG, V89, P587, DOI 10.1016/j.wneu.2015.11.072
  3. Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9
  4. Djurisic S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2099-9
  5. Egawa S, 2016, J CRIT CARE, V32, P52, DOI 10.1016/j.jcrc.2015.11.008
  6. Fontanella MM, 2020, WORLD NEUROSURG, V139, pE818, DOI 10.1016/j.wneu.2020.04.204
  7. Fontelo P, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0819-1
  8. Garg Kanwaljeet, 2022, Acta Inform Med, V30, P11, DOI 10.5455/aim.2022.30.11-17
  9. Garner RM, 2018, J NEUROINTERV SURG, V10, P102, DOI 10.1136/neurintsurg-2017-013265
  10. Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5
  11. Griswold DP, 2020, NEUROSURGERY, V87, P476, DOI 10.1093/neuros/nyaa049
  12. Harper L, 2020, J PEDIATR UROL, V16, P715, DOI 10.1016/j.jpurol.2020.07.002
  13. Jia ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091594
  14. Kanmounye US, 2021, WORLD NEUROSURG, V149, P226, DOI 10.1016/j.wneu.2021.01.121
  15. Kiraz M, 2021, NEURORADIOL J, V34, P482, DOI 10.1177/19714009211012358
  16. Kramer AH, 2020, NEUROCRIT CARE, V32, P80, DOI 10.1007/s12028-019-00858-6
  17. Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076
  18. Kramer AH, 2011, NEUROCRIT CARE, V14, P329, DOI 10.1007/s12028-011-9530-y
  19. Lasch F, 2022, CLIN PHARMACOL THER, V111, P1093, DOI 10.1002/cpt.2534
  20. Lavadi RS, 2022, WORLD NEUROSURG, V167, pE1419, DOI 10.1016/j.wneu.2022.09.051
  21. Lawton MT, 2017, NEW ENGL J MED, V377, P257, DOI 10.1056/NEJMcp1605827
  22. Li L, 2018, WORLD NEUROSURG, V113, pE82, DOI 10.1016/j.wneu.2018.01.164
  23. Liu BL, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4498
  24. Nguyen TN, 2022, J NEUROL NEUROSUR PS, V93, P1028, DOI 10.1136/jnnp-2022-329200
  25. Nichol AD, 2010, INJURY, V41, P20, DOI 10.1016/j.injury.2010.03.033
  26. Pham XX, 2022, JAMA NEUROL, V79, P1049, DOI 10.1001/jamaneurol.2022.2456
  27. Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029
  28. Rai AT, 2020, J NEUROINTERV SURG, V12, P831, DOI 10.1136/neurintsurg-2020-016502
  29. Ramos MB, 2019, NEUROCRIT CARE, V31, P365, DOI 10.1007/s12028-019-00731-6
  30. Rumalla K, 2018, WORLD NEUROSURG, V110, pE100, DOI 10.1016/j.wneu.2017.10.089
  31. Sathian B, 2020, NEPAL J EPIDEMIOL, V10, P878, DOI 10.3126/nje.v10i3.31622
  32. Sohrabi C, 2021, INT J SURG, V86, P57, DOI 10.1016/j.ijsu.2020.12.008
  33. Tosi U, 2021, WORLD NEUROSURG, V148, P251, DOI 10.1016/j.wneu.2020.11.167
  34. Visconti-Lopez FJ, 2022, WORLD NEUROSURG, V165, pE401, DOI 10.1016/j.wneu.2022.06.064
  35. Wijdicks EFM, 2017, HAND CLINIC, V140, P3, DOI 10.1016/B978-0-444-63600-3.00001-5
  36. Wilson M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5840
  37. Zhou J, 2017, J CLIN NEUROSCI, V42, P28, DOI 10.1016/j.jocn.2017.02.057
  38. Zygourakis CC, 2015, NEUROSURG CLIN N AM, V26, P189, DOI 10.1016/j.nec.2014.11.008